New study singles out factors linked to cognitive deficits in type 2 diabetes

September 01, 2010

WASHINGTON -- Older adults with diabetes who have high blood pressure, walk slowly or lose their balance, or believe they're in bad health, are significantly more likely to have weaker memory and slower, more rigid cognitive processing than those without these problems, according to a new study published by the American Psychological Association.

These three health factors stood out from more than a dozen suspected to shape how Type 2 diabetes is frequently shadowed by cognitive impairment, including dementia. An analysis in September's Neuropsychology stresses that although these factors might not actually cause cognitive problems, their presence can warn doctors that such problems may exist or soon develop.

"Awareness of the link between diabetes and cognition could help people realize how important it is to manage this disease--and to motivate them to do so," said co-author Roger Dixon, PhD, of the University of Alberta.

Type 2 diabetes has been found by other researchers to nearly double the risk of dementia and Alzheimer's disease, said Dixon, who studies how health affects cognition in aging. As diabetes becomes more common, this heightened risk could dramatically hike the number of older people with dementia - a double whammy of serious chronic disease. Among people older than 60, the U.S. prevalence of Type 2 diabetes is more than 23 percent, according to the National Institute of Diabetes and Digestive & Kidney Diseases. The Canadian prevalence is nearly 19 percent, according to the Public Health Agency of Canada.

An analysis of older Canadians living in British Columbia -- 41 with Type 2 diabetes (ages 55-81) and 458 matched healthy controls (ages 53-90) -- found that systolic blood pressure (the top number, or maximum pressure on artery walls during a single heartbeat), a low combination score for gait and balance, and a patient's own reports of poor health all played a statistically significant role in the relationship between diabetes and cognitive impairment relationship.

In other words, higher but still normal blood pressure, slower gait and shakier balance, and/or reporting one's self to be in bad health regardless of actual problems boosted the likelihood that someone with Type 2 diabetes had impaired cognition. The relationships were linear: For example, the worse the balance, the higher the likelihood of cognitive problems, as measured by mental speed (reaction time, switching time and perceptual speed), mental control and flexibility (executive functioning), and recall of recent learning (episodic memory).

The results highlight factors that may work indirectly, gradually and cumulatively to make older diabetics more likely to develop dementia. Researchers tested 13 different variables in all, in the areas of general fitness, emotional health, subjective and functional health, and lifestyle activities.

Mediating Factors

Because diabetes and hypertension often go together, Dixon said he was not surprised that high systolic blood pressure accounted for one-third to one-half of significantly worse scores on four tests. That finding, said the authors, suggests that diabetes and cognition may be connected via diabetics' vascular problems. For example, diabetes and hypertension may both play a role in a larger metabolic syndrome that includes high blood sugar and insulin resistance.

However, the other two factors raised new questions. Combined gait and balance had the greatest influence, accounting for between 32 percent and 62 percent of performance on seven cognitive tests. Diabetes might affect the specific nerves that control gait and balance, the authors wrote, or more broadly affect the overlapping brain areas that support both gait-balance and cognition.

Like blood pressure, what people said about their health accounted for about one-third to one-half of performance on five different cognitive tests. Negativity about one's health could reflect related factors such as stress or depression, which did not, in this study, directly mediate between diabetes and cognition. Self-reported health is "an important indicator of ways in which a cluster of health-related beliefs and behaviors can modulate the effect of this disease on cognitive adaptation," Dixon said.

"It's important to pay attention to the health beliefs of older adults, not because they are necessarily accurate or valid indicators of specific health status, but because they might track overall health," Dixon said.

Type 2 diabetes in adults accounts for 90 percent to 95 percent of all diagnosed cases of diabetes, according to the National Institute of Diabetes and Digestive & Kidney Diseases.
-end-
Article: "Testing Covariates of Type 2 Diabetes-Cognition Associations in Older Adults: Moderating or Mediating Effects?" G. Peggy McFall, MSc, and Bonnie P. Geall, BSc, University of Alberta; Ashley L. Fischer, BSc, Simon Fraser University; Sanda Dolcos, PhD, and Roger A. Dixon, PhD, University of Alberta; Neuropsychology, Vol. 24, No. 5.

(Full text of the article is available from the APA Public Affairs Office and at http://www.apa.org/pubs/journals/releases/neu-24-5-547.pdf)

Contact: Dr. Roger Dixon at rdixon@ualberta.ca or (780) 492-5850.

The American Psychological Association, in Washington, D.C., is the largest scientific and professional organization representing psychology in the United States and is the world's largest association of psychologists. APA's membership includes more than 152,000 researchers, educators, clinicians, consultants and students. Through its divisions in 54 subfields of psychology and affiliations with 60 state, territorial and Canadian provincial associations, APA works to advance psychology as a science, as a profession and as a means of promoting health, education and human welfare.

American Psychological Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.